Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models

Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models

Development of a protective and broadly-acting vaccine against the most widely distributed human malaria parasite, Plasmodium vivax, will be a major step towards malaria elimination. However, a P. vivax vaccine has remained elusive by the scarcity of pre-clinical models to test protective efficacy a...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Salman, A, Montoya-Díaz, E, West, H, Lall, A, Atcheson, E, Lopez-Camacho, C, Ramesar, J, Bauza, K, Collins, K, Brod, F, Reis, F, Pappas, L, González-Cerón, L, Janse, C, Hill, A, Khan, S, Reyes-Sandoval, A
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Nature Publishing Group 2017

Míreanna comhchosúla

Tailoring a P. vivax vaccine to enhance efficacy through a combination of a CSP Virus-Like Particle Rv21 and TRAP viral vectors
de réir: Atcheson, E, et al.
Foilsithe / Cruthaithe: (2018)

Protective efficacy of peptides from Plasmodium vivax circumsporozoite protein
de réir: Atcheson, E, et al.
Foilsithe / Cruthaithe: (2020)

A probabilistic model of pre-erythrocytic malaria vaccine combination in mice
de réir: Atcheson, E, et al.
Foilsithe / Cruthaithe: (2019)

Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine
de réir: Alves, E, et al.
Foilsithe / Cruthaithe: (2017)

Efficacy of a Plasmodium vivax malaria vaccine using ChAd63 and modified vaccinia Ankara expressing thrombospondin-related anonymous protein as assessed with transgenic Plasmodium berghei parasites.
de réir: Bauza, K, et al.
Foilsithe / Cruthaithe: (2014)

Vaccine containing the three allelic variants of the Plasmodium vivax circumsporozoite antigen induces protection in mice after challenge with a transgenic rodent Malaria parasite..
de réir: Gimenez, A, et al.
Foilsithe / Cruthaithe: (2017)

Development of novel vaccine candidates and challenge models for Plasmodium vivax
de réir: Alves, E, et al.
Foilsithe / Cruthaithe: (2014)

Tailoring a combination pre-erythrocytic malaria vaccine
de réir: Bauza, K, et al.
Foilsithe / Cruthaithe: (2015)

Evaluation of the transmission-blocking potential of Plasmodium vivax antigen Pvg37 using transgenic rodent parasites and clinical isolates
de réir: Di Zhang, et al.
Foilsithe / Cruthaithe: (2025-01-01)

Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites.
de réir: Mizutani, M, et al.
Foilsithe / Cruthaithe: (2014)

Chimeric Plasmodium falciparum parasites expressing Plasmodium vivax circumsporozoite protein fail to produce salivary gland sporozoites
de réir: Marin-Mogollon, C, et al.
Foilsithe / Cruthaithe: (2018)

The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trials.
de réir: Ramjanee, S, et al.
Foilsithe / Cruthaithe: (2007)

The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment
de réir: Goodman, A, et al.
Foilsithe / Cruthaithe: (2013)

Homologous and heterologous prime boost vaccinations with distinct variants of Plasmodium vivax circumsporozoite protein (CSP) protects mice against transgenic PB/PV sporozoite challenge
de réir: Freitas, E, et al.
Foilsithe / Cruthaithe: (2017)

Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
de réir: Turner, B, et al.
Foilsithe / Cruthaithe: (2008)

The use of transgenic parasites in malaria vaccine research.
de réir: Othman, A, et al.
Foilsithe / Cruthaithe: (2017)

HLA-B27 transgenic rodents express cell surface HLA-B27 heavy chain homodimers and multimers.
de réir: Bowness, P, et al.
Foilsithe / Cruthaithe: (2003)

Acquisition and longevity of antibodies to Plasmodium vivax pre-erythrocytic antigens in western Thailand.
de réir: Longley, R, et al.
Foilsithe / Cruthaithe: (2016)

Acquisition and longevity of antibodies to Plasmodium vivax pre-erythrocytic antigens in western Thailand
de réir: Longley, R, et al.
Foilsithe / Cruthaithe: (2016)

Insights into LRRK2 function and dysfunction from transgenic and knockout rodent models.
de réir: Sloan, M, et al.
Foilsithe / Cruthaithe: (2012)

Assessment of novel liver-stage vaccines using transgenic rodent malaria parasites
de réir: Salman, AM
Foilsithe / Cruthaithe: (2014)

Screening of viral-vectored P. falciparum pre-erythrocytic candidate vaccine antigens using chimeric rodent parasites
de réir: Kolli, SK, et al.
Foilsithe / Cruthaithe: (2021)

Human monoclonal antibodies inhibit invasion of transgenic Plasmodium knowlesi expressing Plasmodium vivax Duffy binding protein
de réir: Watson, QD, et al.
Foilsithe / Cruthaithe: (2023)

Plasmodium vivax susceptibility to ferroquine.
de réir: Leimanis, M, et al.
Foilsithe / Cruthaithe: (2010)

Plasmodium vivax malaria vaccines: why are we where we are?
de réir: Reyes-Sandoval, A, et al.
Foilsithe / Cruthaithe: (2013)

Human Plasmodium vivax diversity, population structure and evolutionary origin
de réir: Rougeron, V, et al.
Foilsithe / Cruthaithe: (2020)

HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors.
de réir: Kollnberger, S, et al.
Foilsithe / Cruthaithe: (2004)

Epidemiology of Plasmodium vivax in Indonesia
de réir: Baird, J, et al.
Foilsithe / Cruthaithe: (2016)

The Vivax Surveyor: Online mapping database for Plasmodium vivax clinical trials.
de réir: Commons, R, et al.
Foilsithe / Cruthaithe: (2017)

Effects of Plasmodium vivax malaria in pregnancy.
de réir: Nosten, F, et al.
Foilsithe / Cruthaithe: (1999)

Targeting vivax malaria in the Asia Pacific: The Asia Pacific Malaria Elimination Network Vivax Working Group
de réir: Anstey, N, et al.
Foilsithe / Cruthaithe: (2015)

Manifestações respiratórias na malária por Plasmodium falciparum e Vivax: vivax
de réir: C. Botelho, et al.
Foilsithe / Cruthaithe: (1987-12-01)

Screening of viral-vectored P. falciparum pre-erythrocytic candidate vaccine antigens using chimeric rodent parasites.
de réir: Surendra Kumar Kolli, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Naturally acquired immunity to vivax malaria.
de réir: Luxemburger, C, et al.
Foilsithe / Cruthaithe: (1999)

Biochemical examination of non-transgenic and transgenic soybean plants under drought stress conditions
de réir: C.G. Gonçalves, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Plasmodium vivax: restricted tropism and rapid remodelling of CD71 positive reticulocytes.
de réir: Malleret, B, et al.
Foilsithe / Cruthaithe: (2014)

Characterisation of Plasmodium vivax lactate dehydrogenase dynamics in P. vivax infections
de réir: Pengxing Cao, et al.
Foilsithe / Cruthaithe: (2024-03-01)

Using fast-scan cyclic voltammetry to investigate monoamine release in BAC transgenic rodent models of Parkinson's Disease
de réir: Potgieter, D
Foilsithe / Cruthaithe: (2014)

Laboratory maintenance of rodent malaria parasites.
de réir: Ramakrishnan, C, et al.
Foilsithe / Cruthaithe: (2013)

Resolving the cause of recurrent Plasmodium vivax malaria probabilistically
de réir: Taylor, A, et al.
Foilsithe / Cruthaithe: (2019)